Although the current study was not designed to investigate the independent effect of BAT on insulin sensitivity, studies in preclinical models have demonstrated that BAT-specific genetic ablation of CL synthesis is sufficient to cause whole-body insulin resistance [13] and that BAT-derived lipid mediators have endocrine functions to improve insulin sensitivity and endocrine function in the muscle and the heart [36,37]. Here, INS is linked to Insulin resistance.